Author(s): Zhou XD, Tang ZY, Yu YQ, Yang BH, Lu JZ,
Abstract Share this page
Abstract The long-term prognosis of surgery for hepatocellular carcinoma (HCC) is not yet satisfactory, the main reason being the high recurrence rate. The authors report the results of a long-term follow-up of 308 patients with HCC who became alpha-fetoprotein-(AFP)-negative after resection between 1975 and 1991. By March 1992, there was recurrence in 134 patients (43.5\%). The 1-, 3-, 5- and 10-year recurrence rates were 9.2\%, 38.8\%, 54.9\% and 85.0\%, respectively. The 5-year survival rate was 49.7\% for patients who had undergone a second hepatic resection (n = 48). Analysis of factors influencing postoperative recurrence indicated that patients subjected to mass survey, with a lower gamma-glutamyltransferase level, at an early stage of TNM classification, with a tumour of less than 5 cm, without tumour embolus, and with postoperative immunotherapy had a lower incidence of recurrence. It is concluded that the earlier the disease is diagnosed, the less the recurrence rate; adjuvant immunotherapy may reduce postoperative recurrence, and the early detection and resection of a recurrent tumour are important to prolonging survival further after curative resection of HCC.
This article was published in J Cancer Res Clin Oncol
and referenced in Journal of Bacteriology & Parasitology